Price Alert

Amedisys Inc. (AMED)

NASDAQ: AMED · Real-Time Price · USD

100.99

0.01 (0.01%)

At close: Aug 14, 2025, 3:59 PM

101.00

0.01%

After-hours: Aug 14, 2025, 07:38 PM EDT

Amedisys Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	2.4B	2.37B	2.35B	2.32B	2.29B	2.25B	2.24B	2.23B	2.23B	2.23B	2.22B	2.22B	2.22B	2.22B	2.21B	2.21B	2.2B	2.12B
Cost of Revenue	1.15B	1.48B	1.6B	1.39B	1.37B	1.2B	1.06B	1.24B	1.25B	1.27B	1.26B	1.26B	1.25B	1.24B	1.23B	1.22B	1.21B	1.2B
Gross Profit	1.26B	894.82M	751.75M	928.5M	923M	1.05B	1.17B	986.4M	977.55M	963.72M	962.77M	960.03M	967.46M	981.25M	980.76M	982.58M	985.79M	920.14M
Operating Income	99.64M	118.18M	127.11M	180.74M	192.62M	166.3M	156.39M	168.62M	165.34M	175.19M	180.77M	182.69M	200.53M	231.03M	251.91M	265.91M	272.45M	244.25M
Interest Income	10.65M	9.26M	8.11M	6.18M	5.47M	4.59M	3.27M	2.52M	1.28M	571K	178K	108K	49K	38K	49K	83K	114K	303K
Pretax Income	149.29M	150.19M	86.22M	134.64M	143.6M	32.14M	39.62M	51.76M	48.63M	151.22M	160.24M	165.79M	186.95M	255.76M	280.23M	295.39M	301.62M	237.63M
Net Income	149.69M	114.39M	67.78M	127.54M	112.04M	-539K	10.31M	2.65M	2.33M	112.18M	118.61M	120.94M	140.3M	190.87M	209.07M	220.18M	247.15M	201.68M
Selling & General & Admin	597.2M	792.95M	604.23M	598.56M	593.21M	610.45M	797.57M	793.96M	789.32M	764.15M	754.06M	745.48M	736.07M	723.47M	711.24M	701.99M	702.67M	683.8M
Research & Development	n/a	n/a	n/a	3.8M	3.8M	3.8M	3.8M	3M	3M	3M	3M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	689.3M	54.41M	-24.74M	441.68M	421.44M	484.78M	547.17M	15.62M	19.89M	21.37M	24.93M	20.2M	15.21M	9.46M	1.75M	1.9M	1.53M	-1.64M
Operating Expenses	1.29B	776.64M	624.64M	888.36M	866M	1.02B	1.15B	812.79M	809.2M	785.52M	778.99M	774.32M	766.92M	750.22M	728.84M	712.51M	709.18M	671.74M
Interest Expense	14.76M	29.07M	30.76M	32.02M	32.27M	31.88M	31.27M	28.82M	25.76M	26.57M	22.23M	19.24M	17M	10.63M	9.53M	9.1M	9.06M	9.88M
Selling & Marketing Expenses	n/a	n/a	-185.89M	-188.55M	-188.55M	-188.55M	-2.66M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	2.43B	2.25B	2.22B	2.28B	2.23B	2.22B	2.22B	2.05B	2.06B	2.06B	2.04B	2.03B	2.02B	1.99B	1.96B	1.94B	1.92B	1.87B
Income Tax Expense	3.93M	39.86M	23.11M	6.64M	31.44M	33.04M	30.2M	50.17M	47.26M	40.33M	42.55M	45.63M	46.94M	64.17M	70.06M	73.65M	52.72M	34.2M
Shares Outstanding (Basic)	32.85M	32.79M	32.72M	32.74M	32.71M	32.67M	32.63M	32.62M	32.58M	32.56M	32.51M	32.48M	32.52M	32.55M	32.59M	32.61M	32.59M	32.78M
Shares Outstanding (Diluted)	32.85M	33.22M	32.72M	33.13M	33.05M	32.98M	32.91M	32.83M	32.58M	32.64M	32.6M	32.62M	32.68M	32.77M	32.82M	32.9M	32.98M	33.19M
EPS (Basic)	4.57	3.50	2.08	3.91	3.44	-0.01	0.33	0.10	0.09	3.46	3.65	3.71	4.30	5.85	6.40	6.74	7.56	6.17
EPS (Diluted)	4.53	3.45	2.05	3.87	3.41	-0.03	0.30	0.07	0.07	3.44	3.64	3.71	4.29	5.81	6.34	6.66	7.45	6.06
EBITDA	164.66M	188.85M	158.05M	198.21M	224.25M	105.25M	94.74M	103.77M	97M	200.41M	208.46M	213.41M	234.35M	297.28M	319.14M	335.1M	342.09M	278.53M
EBIT	166.49M	157.86M	125.37M	175.05M	199.8M	80.96M	70.9M	80.58M	74.4M	177.79M	183.53M	186.09M	205.01M	267.44M	289.76M	304.49M	310.68M	247.51M
Depreciation & Amortization	29M	30.99M	32.68M	23.16M	24.45M	24.29M	23.85M	23.19M	22.6M	22.62M	24.93M	28.84M	30.85M	31.35M	30.9M	40.6M	51.99M	61.1M